Top Markets
Coin of the day
Evaxion Biotech A/S Evaxion Biotech A/S

Evaxion Biotech A/S

EVAX
株式のランク #29740
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to... Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
株価
$3.14
最終同期: 2026-08-18
時価総額
$19.83M
変化(1日)
0.32%
変化(1年)
3.29%
DK
取引 Evaxion Biotech A/S (EVAX)

カテゴリー

Evaxion Biotech A/S(EVAX)の株価履歴
終値の最高値: $3.12 (2026-08-01)

終値の最安値: $427.70 (2021-02-01)
Evaxion Biotech A/S の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -23.56%
2025 -2.32%
2024 -83.73%
2023 -64.17%
2022 -54.86%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$740.28 6.71%
CH
$1.07K -5.58%
KR